The Week On The Horizon: PetMed Express, IceCure Medical, BM Technologies, Rubicon, Ryvyl
- May 20th, 2023
- 270 views
On Monday, May 22, several notable companies are expected to announce their financial results. Here's a closer look at each company's expected performance:
PetMed Express, Inc. (Nasdaq: PETS) will report its financial results for the fourth quarter and full year ended March 31, 2023, after the market closes. Analysts estimate a consensus EPS of $0.14 on revenue of $65.9 million. On Friday, $PETS closed at $14.72, experiencing a decrease of $0.76 (-4.91%).
IceCure Medical Ltd (Nasdaq: ICCM) will release its financial and operational results for the first quarter of 2023 prior to the market opening. The consensus expectation is a loss of $0.09 per share on revenue of $960,000. $ICCM closed at $1.27 on Friday, remaining unchanged (0.00%).
BM Technologies, Inc. (NYSE American: BMTX) will report its first-quarter 2023 earnings after the market closes. Analysts anticipate a consensus loss of $0.50 per share on revenue of $14.87 million. On Friday, $BMTX closed at $2.93, showing an increase of $0.04 (+1.71%).
Rubicon Technologies, Inc. (NYSE: RBT) will release its financial results for the first quarter of 2023 after the market closes. The consensus estimate is a loss of $0.30 per share on revenue of $165.19 million. $RBT closed at $0.71 on Friday, experiencing a gain of $0.17 (+31.53%).
Ryvyl Inc. (Nasdaq: RVYL) is set to report its financial results for the first quarter of 2023 after the market closes. Analysts predict a consensus loss of $0.08 per share on revenue of $12.3 million. On Friday, $RVYL closed at $0.46, reflecting a decrease of $0.01 (-3.36%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025




Member Login